{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-25-001297","form_type":"8-K","ticker":"LNAI","cik":"0001527728","company_name":"Lunai Bioworks Inc.","filed_at":"2025-09-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.232210+00:00","generated_at":"2026-05-17T05:46:16.203433+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Lunai Bioworks 1-for-10 reverse stock split effective Sept 29; new ticker LNAI","bullets":["Share consolidation at 1-for-10 ratio begins 12:01 a.m. ET on September 29, 2025.","Outstanding shares will shrink from ~231.8M to ~23.2M; authorized shares unchanged at 350M.","Stockholders approved the split range (1:3 to 1:10) on August 15, 2025; board chose 1:10.","Common stock starts trading split-adjusted on Nasdaq Sept 30 under symbol LNAI; new CUSIP 29350E203.","Fractional shares rounded up to the next whole share; par value remains $0.0001 per share."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-25-001297","json":"https://secwatch.observer/filing/0001731122-25-001297.json","markdown":"https://secwatch.observer/filing/0001731122-25-001297.md","text":"https://secwatch.observer/filing/0001731122-25-001297.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1527728/000173112225001297/0001731122-25-001297-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1527728/000173112225001297/e6874_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:46:16.203433+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fb82bf513e5d4d2c930afecec52c38d177709673","claim":"Lunai Bioworks Inc.: Filed Certificate of Amendment to effect a 1-for-10 reverse stock split of common stock, par value unchanged, effective September 29, 2025; authorized shares unchanged at 350,000,000 (effective 2025-09-29).","evidence_excerpt":"On September 18, 2025, Lunai Bioworks, Inc. (the “ Company ”) filed a Certificate of Amendment to the Certificate of Incorporation of the Company (the “ Certificate of Amendment ”) with the Secretary of State of the State of Delaware to effect a 1-for-10 reverse stock split of the shares of the Company’s common stock, par value $0.0001 per share (the “ Common Stock ”), either issued and outstanding or held by the Company as treasury stock, effective as of 12:01 a.m. (New York time) on September 29, 2025 (the “ Reverse Stock Split ”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112225001297/0001731122-25-001297-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-09-29"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}